共同药业：累计回购公司股份197500股
Group 1 - The company announced a share buyback program, having repurchased a total of 197,500 shares as of July 31, 2025, which represents 0.17% of its current total share capital [1]
Group 1 - The company announced a share buyback program, having repurchased a total of 197,500 shares as of July 31, 2025, which represents 0.17% of its current total share capital [1]